Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Jan 20, 2023 6:08pm
207 Views
Post# 35236699

RE:Here's my best i-Dialco guess

RE:Here's my best i-Dialco guess

The issue IS the not knowing/ guessing.

 

Without disclosure we do not know..

 

How will i-Dialco be funded? If Infomed brings on Partners or does a financing- what does that do to Spectral's percentage?

 

Infomed doesn’t even mention the FDA trial for DIMI. It is very conspicuously absent from their note. So what do they see as the way forward for DIMI?

 

Why was Infomed able to take back control of DIMI and SAMI? What contractural obligations did Spectral not meet back in June and in November?

 

Was Spectral’s BOD aware before the AGM that Spectral would not be able to fulfill the Infomed contractural obligations ten days later- and that the control of DIMI and SAMI were in jeparody? 

If the BOD did know, did they still sign off on Spectral’s AGM presentation- Including the Dialco update titled “Perception vs. Reality”?

We were told Sam Amory would stay on to head i-Dialco- that now also looks to be untrue.

 

It’s time for full and honest disclosure. 

 

Shareholders gave Spectral their money to fund DIMI and SAMI for years. Clear disclosure on what has happened to these assets is the very least of Spectral’s obligations.

<< Previous
Bullboard Posts
Next >>